Open Citations
A Randomized, Open-Label, Active-Controlled, Phase 3 Clinical Trial of FDC Erdosteine 300 mg and Acebrophylline 100 mg Tablet versus FDC Acebrophylline 100 mg and Acetylcysteine 600 mg Tablet in Treatment of Chronic Bronchitis in Participants with Chronic Obstructive Pulmonary Disease
0
Open Citations
Last updated: 2026-10-06 08:21:44
Citing Works
No open citing works have been identified for this article yet.